Access brought to you by: LOCKSS

Cardiology Clinical Trials

Methylprednisolone Not Beneficial in High-Risk Cardiac Surgery Patients (SIRS)
Metformin Doses Not Reduce Heart Failure after STEMI in Patients without Diabetes (GIPS-III)
Bariatric Surgery for Treatment of Type 2 Diabetes in Obese Patients: 3-Year Outcomes (STAMPEDE)
TOPCAT: Effects of Spironolactone on CV Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
Risk of Major Cardiovascular or Cerebrovascular Events after PCI or CABG Increased in Diabetes Mellitus Patients Receiving Insulin
Adverse Effects Associated with Varespladib in the VISTA-16 Trial
Thrombectomy Does Not Prevent Microvascular Obstruction in Patients Undergoing PCI for NSTEMI
Endovascular Revascularization Plus Supervised Exercise May Benefit Intermittent Claudication Patients
EU-PACT Study: Initial Warfarin Dosing Improved by Clinical Variables and Genotype to Guide Therapy
COAG Trial: No Advantage Seen with Genetic-Based Warfarin Dosing

Pages